By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GenKyoTex S.A.  

16, Chemin des Aulx
CH-1228, Plan-Les-Ouates
  Geneva    Switzerland
Phone: 41-0-22-880-10-25 Fax: 41-0-22-880-10-13


Company News
GenKyoTex S.A. 's GKT137831 Granted Orphan Drug Designation In The US And EU For The Treatment Of Systemic Sclerosis 11/11/2015 11:25:00 AM
GenKyoTex S.A. Announces Leadership Transition 9/29/2015 11:00:29 AM
GenKyoTex S.A. CEO Resigns 9/29/2015 6:03:31 AM
GenKyoTex S.A. Announces Top-Line Results Of Phase 2 Clinical Program 9/9/2015 10:59:43 AM
GenKyoTex S.A. ’s NOX1&4 Inhibitor Strategy In Liver Fibrosis Supported By New Preclinical Results 7/30/2015 11:40:04 AM
GenKyoTex S.A. Raises CHF 20 Million ($21 Million) 1/7/2015 6:23:25 AM
GenKyoTex S.A. Completes Enrollment Into Phase 2 Trial Of NOX1&4 Inhibitor GKT137831 In Diabetic Nephropathy 11/13/2014 10:56:51 AM
GenKyoTex S.A. Announces New Senior Management And Board Appointments 5/19/2014 6:47:44 AM
GenKyoTex S.A. 's GKT137831 Found To Reverse Fibrosis And Improve Survival In A Model Of Persistent Lung Fibrosis 4/10/2014 9:22:56 AM
GenKyoTex S.A. NOX Inhibitor GKT137831 Successfully Shown To Halt Diabetic Kidney Disease 11/11/2013 9:06:20 AM